SelectScience InterviewsClinical Diagnostics
ELITech Discusses Acquisition of Vital Diagnostics
7 Aug 2013
Watch this video to see Bill Schreiber from the Eli Tech Group discussing the company’s recent acquisition of Vital Diagnostics. With products sold in over 100 countries, Vital Diagnostics is a leading player in the US clinical chemistry market, as well as a leading distributor of in vitro diagnostic analyzers and tests in Australia and New Zealand.